AVZO-1418

· Avenzo Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVZO-1418, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) [Phase 1, Phase 2]

See pricing